glp-1 and bowel obstruction Association of receptor agonists with risk of intestinal in patients with type 2 diabetes mellitus: a retrospective cohort study | Acta Diabetologica Constipation and GLP-1 Medications: What
Description
doi: 10.2147/DDDT.S506957, 101 Montrose-RafizadehC.EganJ
A hydration guide for people on GLP-1s A hydration guide for people on GLP-1s Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are used to treat obesity, Type 2 diabetes, and more
Patients initiating GLP-1 RAs were less likely to start additional preventive medications, including valproate (risk ratio 0.52), calcitonin gene-related peptide monoclonal antibodies (risk ratio 0.58), tricyclic antidepressants (risk ratio 0.65), and gepants (risk ratio 0.77)
Get personalized nutrition counselling and fitness plans
